Baseline characteristics associated with survival in patients with hepatocellular carcinoma

Seymur Aslanov1, Nalan Gulsen Unal1, Ali Senkaya1

  • 1Division of Gastroenterology, Department of Internal Medicine, University of Ege School of Medicine, Izmir, Turkey.

Hepatology Forum
|July 5, 2022
PubMed

Insights

This study identified key factors influencing survival in hepatocellular carcinoma (HCC) patients. A prognostic index based on these factors accurately predicts long-term survival, aiding treatment decisions.

Area of Science:

  • Hepatology
  • Oncology
  • Medical Statistics

Background:

  • Hepatocellular carcinoma (HCC) is a significant global health challenge.
  • Identifying prognostic factors is crucial for patient management and treatment strategies.

Purpose of the Study:

  • To investigate the relationship between baseline parameters and survival in HCC patients.
  • To develop and validate a prognostic index for HCC survival prediction.

Main Methods:

  • Retrospective analysis of 788 HCC patients' data from 2000-2017.
  • Collection of demographic, clinical, laboratory, and radiological characteristics.
  • Calculation of prognostic scores and survival analysis.

Main Results:

  • Median survival was 26.3 months, with a 5-year survival rate of 28.1%.
  • Tumor characteristics (number, diameter), platelet count, platelet-to-lymphocyte ratio, liver enzymes (AST, ALT, GGT), vascular involvement, and alpha-fetoprotein levels were independent predictors of survival.
  • A prognostic index demonstrated an 86% predictive value for 5- and 10-year survival.

Conclusions:

  • Established prognostic factors significantly impact HCC patient survival.
  • The developed prognostic index offers a valuable tool for predicting survival and informing treatment decisions in HCC management.
Abstract

Related Concept Videos